Clinical Trials
7 trialsNCT01852890 2025-10-24
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
University of Iowa
Phase 1 Completed
NCT02349867 2022-09-19
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer
Virginia Commonwealth University
Phase 1 Completed
NCT01908478 2020-07-15
VelGemRad
Cedars-Sinai Medical Center
Phase 1 Completed
NCT01661088 2019-11-13
A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00609336 2017-07-13
Perioperative Therapy for Resectable Pancreatic Cancer
University of Washington
Phase 2 Completed
NCT00593866 2015-09-11
Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer
University of Michigan Rogel Cancer Center
Phase 1/2 Completed
NCT01118897 2015-08-07
Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers
Tata Memorial Hospital
Phase 1/2 Completed